1. Recombinant fusion proteins FPTD-Grb2-SH2 and FPTD-Grb2-SH2M inhibit the proliferation of breast cancer cells in vitro
   JIKAI YIN et al, 2014, Oncology Reports CrossRef
2. Potential pharmacological mechanisms of tanshinone IIA in the treatment of human neuroblastoma based on network pharmacological and molecular docking Technology
   Ning Tang et al, 2024, Frontiers in Pharmacology CrossRef
3. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2
   Yunda Zhang et al, 2016, Biochemical and Biophysical Research Communications CrossRef
4. Subcellular Dynamic Immunopatterning of Cytosolic Protein Complexes on Microstructured Polymer Substrates
   Roland Hager et al, 2021, ACS Sensors CrossRef
5. A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
   Yuetong Liu et al, 2023, Molecules CrossRef
6. Anti-c-MET Fab-Grb2-Gab1 Fusion Protein-Mediated Interference of c-MET Signaling Pathway Induces Methuosis in Tumor Cells
   Xiaoqian Dou et al, 2022, International Journal of Molecular Sciences CrossRef
7. MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells
   Shanliang Zhong et al, 2015, Gene CrossRef